Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Peripheral nerve block for painful diabetic neuropathy

Official title: Peripheral Nerve Block in Patients With Painful Diabetic Polyneuropathy: How Important is the Peripheral Signaling?

Run by University of Aarhus · NCT04699734 · Data updated 2026-11-12

This study is testing if a nerve block can help adults with painful diabetic neuropathy feel less pain without stopping their regular medications.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment16 (estimated)
SponsorUniversity of Aarhus
Academic / other
Locations1 site (Aarhus N, Jutland)
StatusRecruiting
StartedSeptember 8, 2020
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedJanuary 7, 2021
Trial IDNCT04699734 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older with confirmed painful diabetic neuropathy and a pain intensity rating above 4 on the NRS scale.

Probably not a fit

Patients with other identifiable causes of pain, severe psychiatric conditions, or contraindications to regional anesthesia may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of a peripheral regional nerve block in relieving spontaneous pain associated with painful diabetic polyneuropathy. It aims to understand the role of peripheral afferent input in pain generation by administering Xylocaine 1% and NaCl to participants. The study includes adults aged 18 and older who have confirmed diabetic neuropathy and have experienced neuropathic pain for at least six months. Participants will not need to discontinue their pain medications during the study.

Why it matters

Potential benefit: If successful, this approach could significantly alleviate pain for patients suffering from diabetic neuropathy.

How similar studies have gone: While similar approaches have been explored, the specific application of peripheral nerve blocks for this condition remains novel and under-researched.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Aged 18 years or older.
* Probably diabetic neuropathy confirmed using the Toronto criteria in a "conservative manner", i.e. three out of three symptoms/signs of neuropathy must be present (sensory neuropathy symptoms, distal reduced sensibility, reduced ankle reflexes) 7.
* Definite or probable neuropathic pain for minimum the last 6 months
* Mean pain intensity at \> 4 NRS the last week17.

Since we expect a large effect of the block it is not necessary to discontinue pain medication.

Exclusion Criteria:

* Other causes of pain in the same area or other pain that cannot be distinguished from the neuropathic pain.
* Unable to understand and speak Danish.
* Non-cooperative.
* Warfarin or other medication that contraindicate regional anesthesia.
* Infection in the injection area.
* Allergy to lidocaine.
* Pregnancy or lactating (fertile women must to show negative pregnancy test or use anticonception).
* Severe psychiatric disease e.g. severe depression during the last 6 months.
* Alcohol or drug abuse.

Where it's running

  • Danish Pain Research Center, Aarhus University, Aarhus University Hospital
    Aarhus N, Jutland, Denmark
    Recruiting

Study contacts

  • Principal investigator: Ellen L Schaldemose, MD — Danish Pain Research Center, Aarhus University
  • Study coordinator: Ellen L Schaldemose, MD
  • Email: ells@clin.au.dk
  • Phone: +45 93501942

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.